Fingerprint
Dive into the research topics of 'Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis
Ludwig Kappos, Douglas L. Arnold, Amit Bar-Or, A. John Camm, Tobias Derfuss, Till Sprenger, Martin Davies, Alexandra Piotrowska, Pingping Ni, Tomohiko Harada
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations